The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
STAT3 as a target for inducing apoptosis in solid and hematological tumors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Matsuda, T., Tanaka, Y., Ohshiro, K., & Mori, N. (2006) · Retrovirology · doi:10.1186/1742-4690-3-22 · Cited by 50
RetractedPark, S., Kim, D., Kaneko, S., Szewczyk, K. M., Nicosia, S. V., Yu, H., Jove, R., & Cheng, J. Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504011200 · Cited by 49
RetractedUntangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Self-citationCatlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Self-citationMPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Pikman, Y., Lee, B. H., Mercher, T., McDowell, E., Ebert, B. L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030270 · Cited by 1,449
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Self-citationTranscription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,185
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Burtness, B., Goldwasser, M. A., Flood, W., Mattar, B., & Forastiere, A. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4646 · Cited by 879
Shuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., & Darnell, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90357-3 · Cited by 807
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 788
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Siddiquee, K., Zhang, S., Guida, W. C., Blaskovich, M. A., Greedy, B., Lawrence, H. R., Yip, M. L. R., Jove, R., McLaughlin, M. M., Lawrence, N. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609757104 · Cited by 736
Self-citationYoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., Bulmer, S. E., Frank, D. A., Hahn, W. C., Sellers, W. R., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020313 · Cited by 677
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Self-citationSTAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Self-citationEpling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633
Self-citationStat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 598
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4227 · Cited by 588
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576
Self-citationGritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1752 · Cited by 563
Self-citationBlaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 561
Self-citationWei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
Wei, L.-H., Kuo, M.-L., Chen, C.-A., Chou, C.-H., Lai, K.-B., Lee, C.-N., & Hsieh, C.-Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206226 · Cited by 536
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 533
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
SOCS: physiological suppressors of cytokine signaling
Krebs, D. L., & Hilton, D. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2813 · Cited by 463
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Self-citationRegulation of gene-activation pathways by PIAS proteins in the immune system
Shuai, K., & Liu, B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1667 · Cited by 447
Garcia, R., Yu, C., Hudnall, A. M., Catlett, R., Nelson, K. L., Smithgall, T. E., Fujita, D. J., Ethier, S. P., & Jove, R. (1997) · PubMed · Cited by 441
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., & Yu, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205859 · Cited by 432
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 430
Self-citationSTAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
Activation of Stat3 in Human Melanoma Promotes Brain Metastasis
Xie, T.-X., Huang, F.-J., Aldape, K. D., Kang, S.-H., Liu, M., Gershenwald, J. E., Xie, K., Sawaya, R., & Huang, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2674 · Cited by 393
Role of Stat3 in Regulating p53 Expression and Function
Niu, G., Wright, K. L., Ma, Y., Wright, G. M., Huang, M., Irby, R., Briggs, J., Karras, J., Cress, W. D., Pardoll, D., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7432-7440.2005 · Cited by 392
Modulation of STAT signaling by STAT-interacting proteins
Shuai, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203522 · Cited by 379
Rahaman, S. O., Harbor, P. C., Chernova, O., Barnett, G. H., Vogelbaum, M. A., & Haque, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206047 · Cited by 377
Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells
Nam, S., Kim, D., Cheng, J. Q., Zhang, S., Lee, J.-H., Buettner, R., Mirosevich, J., Lee, F. Y., & Jove, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1731 · Cited by 377
STAT signaling in head and neck cancer
Song, J. I., & Grandis, J. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203483 · Cited by 374
Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., & Gallick, G. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208513 · Cited by 372
Iwamaru, A., Szymanski, S., Iwado, E., Aoki, H., Yokoyama, T., Fokt, I., Hess, K., Conrad, C., Madden, T., Sawaya, R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210031 · Cited by 370
Song, L., Turkson, J., Karras, J. G., Jove, R., & Haura, E. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206479 · Cited by 362
Self-citationJak-STAT Signaling Induced by the v- abl oncogene
Danial, N. N., Pernis, A., & Rothman, P. B. (1995) · Science · doi:10.1126/science.7569929 · Cited by 325
Real, P. J., Sierra, A., de Juan, A., Segovia, J. C., Lopez-Vega, J. M., & Fernandez-Luna, J. L. (2002) · Oncogene · doi:10.1038/sj.onc.1206004 · Cited by 321
Weber-Nordt, R., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V, Mertelsmann, R., & Finke, J. (1996) · Blood · doi:10.1182/blood.v88.3.809.809 · Cited by 314
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 312
Galm, O., Yoshikawa, H., Esteller, M., Osieka, R., & Herman, J. G. (2003) · Blood · doi:10.1182/blood-2002-06-1735 · Cited by 308
Validating Stat3 in cancer therapy
Darnell, J. E. (2005) · Nature Medicine · doi:10.1038/nm0605-595 · Cited by 307
Kanda, N., Seno, H., Konda, Y., Marusawa, H., Kanai, M., Nakajima, T., Kawashima, T., Nanakin, A., Sawabu, T., Uenoyama, Y., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207606 · Cited by 302
STAT proteins as novel targets for cancer drug discovery
Turkson, J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.409 · Cited by 295
Self-citationIndirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
Nam, S., Buettner, R., Turkson, J., Kim, D., Cheng, J. Q., Muehlbeyer, S., Hippe, F., Vatter, S., Merz, K.-H., Eisenbrand, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409467102 · Cited by 294
Self-citationAlas, S., & Bonavida, B. (2001) · PubMed · Cited by 293
Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20050465 · Cited by 291
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Self-citationKotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 283
Self-citationTargeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 280
Activation of STAT proteins and growth control
Bromberg, J. F. (2001) · BioEssays · doi:10.1002/1521-1878(200102)23:2<161::aid-bies1023>3.0.co;2-0 · Cited by 279
Lou, W., Ni, Z., Dyer, K., Tweardy, D. J., & Gao, A. C. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000215)42:3<239::aid-pros10>3.0.co;2-g · Cited by 278
(2003) · PubMed · Cited by 272
Pardanani, A., Hood, J., Lasho, T., Levine, R. L., Martin, M. B., Noronha, G., Finke, C., Mak, C. C., Mesa, R., Zhu, H., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404750 · Cited by 272
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
Burke, W. M., Jin, X., Lin, H.-J., Huang, M., Liu, R., Reynolds, R. K., & Lin, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204990 · Cited by 269
Survivin: A promising tumor biomarker
Duffy, M. J., O’Donovan, N., Brennan, D. J., Gallagher, W. M., & Ryan, B. M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.020 · Cited by 267
Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
Self-citationScholz, A., Heinze, S., Detjen, K. M., Peters, M., Welzel, M., Hauff, P., Schirner, M., Wiedenmann, B., & Rosewicz, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01064-3 · Cited by 256
Turkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.261.3.3 · Cited by 255
Self-citationFrost, M. J., Ferrao, P. T., Hughes, T. P., & Ashman, L. K. (2002) · PubMed · Cited by 249
Duan, Z., Foster, R., Bell, D. A., Mahoney, J., Wolak, K., Vaidya, A., Hampel, C., Lee, H., & Seiden, M. V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0861 · Cited by 247
Diaz, N., Minton, S., Cox, C., Bowman, T., Gritsko, T., Garcia, R., Eweis, I., Wloch, M., Livingston, S., Seijo, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1749 · Cited by 242
Alas, S., & Bonavida, B. (2003) · PubMed · Cited by 240
Activation of STAT3 is a marker of poor prognosis in human colorectal cancer
Kusaba, T., Nakayama, T., Yamazumi, K., Yakata, Y., Yoshizaki, A., Inoue, K., Nagayasu, T., & Sekine, I. (2006) · Oncology Reports · doi:10.3892/or.15.6.1445 · Cited by 238
Berishaj, M., Gao, S. P., Ahmed, S., Leslie, K., Al-Ahmadie, H., Gerald, W. L., Bornmann, W., & Bromberg, J. F. (2007) · Breast Cancer Research · doi:10.1186/bcr1680 · Cited by 236
Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells
Konnikova, L., Kotecki, M., Kruger, M. M., & Cochran, B. H. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-23 · Cited by 217
Constitutive Activation of JAK3/STAT3 in Colon Carcinoma Tumors and Cell Lines
Lin, Q., Lai, R., Chirieac, L. R., Li, C., Thomazy, V. A., Grammatikakis, I., Rassidakis, G. Z., Zhang, W., Fujio, Y., Kunisada, K., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61187-x · Cited by 207
Song, L., Morris, M., Bagui, T., Lee, F. Y., Jove, R., & Haura, E. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4620 · Cited by 204
Zhuang, L., Lee, C. S., Scolyer, R. A., McCarthy, S. W., Zhang, X. D., Thompson, J. F., & Hersey, P. (2007) · Modern Pathology · doi:10.1038/modpathol.3800750 · Cited by 202
Loeffler, S., Fayard, B., Weis, J., & Weissenberger, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20871 · Cited by 200
Nielsen, M., Kæstel, C., Eriksen, K., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401415 · Cited by 197
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Self-citationSiddiquee, K. A. Z., Gunning, P. T., Glenn, M., Katt, W. P., Zhang, S., Schroeck, C., Sebti, S. M., Jove, R., Hamilton, A. D., & Turkson, J. (2007) · ACS Chemical Biology · doi:10.1021/cb7001973 · Cited by 187
Self-citationControl mechanism of JAK/STAT signal transduction pathway
Yamada, S., Shiono, S., Joo, A., & Yoshimura, A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03842-5 · Cited by 184
Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck
Xi, S., Zhang, Q., Dyer, K. F., Lerner, E. C., Smithgall, T. E., Gooding, W. E., Kamens, J., & Grandis, J. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303499200 · Cited by 180
Kusaba, T., Nakayama, T., Yamazumi, K., Yakata, Y., Yoshizaki, A., Nagayasu, T., & Sekine, I. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.023416 · Cited by 173
Xi, S., Gooding, W. E., & Grandis, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208316 · Cited by 170
Schaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
Stat3 activation in human endometrial and cervical cancers
Chen, C.-L., Hsieh, F.-C., Lieblein, J. C., Brown, J., Chan, C., Wallace, J. A., Cheng, G., Hall, B. M., & Lin, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603597 · Cited by 169
Leu, C.-M., Wong, F.-H., Chang, C., Huang, S.-F., & Hu, C.-P. (2003) · Oncogene · doi:10.1038/sj.onc.1207084 · Cited by 168
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
木島, 太., Niwa, H., Steinman, R. A., Drenning, S. D., Gooding, W. E., Wentzel, A. L., Xi, S., & Grandis, J. R. (2002) · PubMed · Cited by 164
Eriksen, K., Kaltoft, K., Mikkelsen, G., Nielsen, M., Zhang, Q., Geisler, C., Nissen, M., Röpke, C., Wasik, M., & Ødum, N. (2001) · Leukemia · doi:10.1038/sj.leu.2402093 · Cited by 162
Han, S., Hwang, P. G., Chung, D. H., Kim, D., Im, S., Kim, Y. T., Kim, T., Heo, D. S., Bang, Y., & Kim, N. K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20550 · Cited by 159
Turkson, J., Zhang, S., Mora, L. B., Burns, A. C., Sebti, S. M., & Jove, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502694200 · Cited by 153
Self-citationTargeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development
Kamath, S., & Buolamwini, J. K. (2006) · Medicinal Research Reviews · doi:10.1002/med.20070 · Cited by 152
Tam, L., McGlynn, L. M., Traynor, P., Mukherjee, R., Bartlett, J. M. S., & Edwards, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603871 · Cited by 143
Flowers, L. O., Subramaniam, P. S., & Johnson, H. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208437 · Cited by 137
Yau, C. Y. F., Wheeler, J. J., Sutton, K. L., & Hedley, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2940 · Cited by 136
Woetmann, A., Nielsen, M., Christensen, S. T., Brockdorff, J. L., Kaltoft, K., Engel, A., Skov, S., Brender, C., Geisler, C., Svejgaard, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10620 · Cited by 133
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 133
Gao, L., Zhang, L., Hu, J., Li, F., Shao, Y., Zhao, D., Kalvakolanu, D. V., Kopecko, D. J., Zhao, X., & Xu, D.-Q. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0148 · Cited by 131
The STAT3 oncogene as a predictive marker of drug resistance
Barré, B., Vigneron, A. M., Perkins, N. D., Roninson, I. B., Gamelin, E. C., & Coqueret, O. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.001 · Cited by 129
Niu, G., Shain, K. H., Huang, M., Ravi, R. K., Bedi, A., Dalton, W. S., Jove, R., & Yu, H. (2001) · PubMed · Cited by 127
Epidermal Growth Factor Receptor–Mediated Stat3 Signaling Blocks Apoptosis in Head and Neck Cancer
Grandis, J. R., Zeng, Q., & Drenning, S. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200005000-00016 · Cited by 125
Besser, D., Bromberg, J., Darnell, J. E., Jr., & Hanafusa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1401 · Cited by 123
Toyonaga, T., Nakano, K., Nagano, M., Zhao, G., Yamaguchi, K., Kuroki, S., Eguchi, T., Chijiiwa, K., Tsuneyoshi, M., & Tanaka, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00482-8 · Cited by 122
SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia
Chen, C.-Y., Tsay, W., Tang, J.-L., Shen, H., Lin, S.-W., Huang, S.-Y., Yao, M., Chen, Y.-C., Shen, M., Wang, C.-H., et al. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10222 · Cited by 121
Xu, H., Yu, Y., Marciniak, D. J., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0280 · Cited by 121
Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis
Kim, D. J., Chan, K. S., Sano, S., & DiGiovanni, J. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20342 · Cited by 117
Constitutive activation of STAT transcription factors in acute myelogenous leukemia
Spiekermann, K., Biethahn, S., Wilde, S., Hiddemann, W., & Alves, F. (2001) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2001.t01-1-00385.x · Cited by 113
Schlessinger, K., & Levy, D. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0317 · Cited by 112
Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia
Warmuth, M., Damoiseaux, R. D., Liu, Y., Fabbro, D., & Gray, N. S. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454126 · Cited by 111
BCR–ABL activates STAT3 via JAK and MEK pathways in human cells
Coppo, P., Flamant, S., Mas, V. M., Jarrier-Gaillard, P., Guillier, M., Bonnet, M., Lacout, C., Guilhot, F., Vainchenker, W., & Turhan, A. G. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06161.x · Cited by 110
Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck
Lund, T. C., Garcia, R., Medveczky, M. M., Jove, R., & Medveczky, P. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6677-6682.1997 · Cited by 105
Apoptosis in human cancer cells
Yu, J., & Zhang, L. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00005 · Cited by 100
Yakata, Y., Nakayama, T., Yoshizaki, A., Kusaba, T., Inoue, K., & Sekine, I. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.437 · Cited by 99
Lee, S. O., Lou, W., Qureshi, K. M., Mehraein‐Ghomi, F., Trump, D. L., & Gao, A. C. (2004) · The Prostate · doi:10.1002/pros.20072 · Cited by 97
Grandis, J. R., Chakraborty, A., Zeng, Q., Melhem, M. F., & Tweardy, D. J. (1998) · Journal of Cellular Biochemistry · Cited by 97
Targeting Stat3 with G-Quartet Oligodeoxynucleotides in Human Cancer Cells
Jing, N., Li, Y., Xu, X., Sha, W., Li, P., Feng, L., & Tweardy, D. J. (2003) · DNA and Cell Biology · doi:10.1089/104454903770946665 · Cited by 96
STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P
Horiguchi, A., Oya, M., Marumo, K., & Murai, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00206.x · Cited by 94
Zong, C. S., Zeng, L., Jiang, Y., Sadowski, H. B., & Wang, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28065 · Cited by 92
Selander, K. S., Li, L., Watson, L., Merrell, M. A., Dahmen, H., Heinrich, P. C., Müller‐Newen, G., & Harris, K. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2516 · Cited by 92
Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839
Albanell, J., Rojo, F., & Baselga, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90283-0 · Cited by 88
Pu, Y., Hour, T., Chuang, S., Cheng, A., Lai, M., & Kuo, M. (2004) · The Prostate · doi:10.1002/pros.20057 · Cited by 88
Design, synthesis, and studies of small molecule STAT3 inhibitors
Bhasin, D. K., Cisek, K. K., Pandharkar, T., Regan, N., Li, C., Pandit, B., Lin, J., & Li, P. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.031 · Cited by 88
HER2/neu in systemic therapy for women with breast cancer: a systematic review
Dhesy-Thind, B., Pritchard, K. I., Messersmith, H. J., O’Malley, F. P., Elavathil, L. J., & Trudeau, M. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9656-y · Cited by 85
The role of cetuximab in the treatment of squamous cell cancer of the head and neck
Burtness, B. A. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.8.1085 · Cited by 78
Wen, X., Lin, H., Shih, H., Kung, H.-J., & Ann, D. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38204 · Cited by 72
Lee, Y. K., Isham, C. R., Kaufmann, S. H., & Bible, K. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0235 · Cited by 62
Nagai, H., Kim, Y., Konishi, N., Baba, M., Kubota, T., Yoshimura, A., & Emi, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00244-6 · Cited by 60
Lund, T. C., Prator, P. C., Medveczky, M. M., & Medveczky, P. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1689-1694.1999 · Cited by 56
Kim, K. W., Mutter, R. W., Cao, C., Albert, J. M., Shinohara, E. T., Sekhar, K. R., & Lü, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0261 · Cited by 54
Trevino, J. G., Gray, M. J., Nawrocki, S. T., Summy, J. M., Lesslie, D. P., Evans, D. B., Sawyer, T. K., Shakespeare, W. C., Watowich, S. S., Chiao, P. J., et al. (2006) · Angiogenesis · doi:10.1007/s10456-006-9038-9 · Cited by 52
Thomas, C. Y., Chouinard, M. L., Cox, M., Parsons, S. J., Stallings‐Mann, M. L., Garcia, R., Jove, R., & Wharen, R. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.10880 · Cited by 50
Vincent, P. W., Bridges, A. J., Dykes, D. J., Fry, D. W., Leopold, W. R., Patmore, S. J., Roberts, B. J., Rose, S., Sherwood, V., Zhou, H., et al. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050034 · Cited by 47
Ikuta, K., Takemura, K., Kihara, M., Nishimura, M., Ueda, N., Naito, S., Lee, E., Shimizu, E., & Yamauchi, A. (2005) · PubMed · Cited by 43
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
de Azambuja, E., Durbecq, V., Rosa, D. D., Colozza, M., Larsimont, D., Piccart, M. J., & Cardoso, F. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm352 · Cited by 43
Nepomuceno, R. R., Snow, A. L., Beatty, P. R., Krams, S. M., & Martinez, O. M. (2002) · Transplantation · doi:10.1097/00007890-200208150-00017 · Cited by 42
Burger, R., Bakker, F., Guenther, A., Baum, W., Schmidt‐Arras, D., Hideshima, T., Tai, Y., Shringarpure, R., Catley, L. P., Senaldi, G., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04686.x · Cited by 39
Schaefer, L. K., Menter, D. G., & Schaefer, T. S. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00077-7 · Cited by 39
Paillaud, É., Costa, S. L., Fages, C., Plassat, J., Rochette‐Egly, C., Monville, C., & Tardy, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10110 · Cited by 31
Apoptosis in multiple myeloma: Therapeutic implications
Chauhan, D., & Anderson, K. C. (2001) · APOPTOSIS · doi:10.1023/a:1009620027205 · Cited by 30
Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells
Kirito, K., Nagashima, T., Ozawa, K., & Komatsu, N. (2002) · International Journal of Hematology · doi:10.1007/bf02981979 · Cited by 24
Hodge, D. R., Xiao, W., Wang, L. H., Li, D., & Farrar, W. L. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.621 · Cited by 22
Samaan, A., & Mahana, W. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.01.008 · Cited by 11
Cited by
NF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2011) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Zhang, S., Huang, W.-C., Li, P., Guo, H., Poh, S.-B., Brady, S. W., Xiong, Y., Tseng, L.-M., Li, S.-H., Ding, Z., et al. (2011) · Nature Medicine · doi:10.1038/nm.2309 · Cited by 515
Targeting STAT3 in cancer: how successful are we?
Yue, P., & Turkson, J. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802565791 · Cited by 413
Self-citationSubramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 278
Metadata
- Authors
- Al Zaid Siddiquee, K., & Turkson, J.
- Venue
- Cell Research
- Published
- 2008-01-29
- Volume
- 18
- Issue
- 2
- Pages
- 254-267
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2137648328
- Cited by
- 487
- References
- 159
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.